Accelerator Directory / Institute Of Cancer Research: Royal Cancer Hospital (the)
We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. Together with our hospital partner The Royal Marsden NHS Foundation Trust, we are rated in the top four centres for cancer research and treatment worldwide.
As well as being as world-class research institute, the ICR is a higher education institution and a college of the University of London. We came top in the league table of university research quality compiled from the Research Excellence Framework (REF 2014).
The ICR has charitable status and relies on support from partner organisations, charities, donors and the general public.
The ICR is led by Chief Executive, Professor Paul Workman — an expert in cancer drug discovery.
The majority of ICR employees are directly engaged in research, but there are also important roles in scientific facilities, academic services, IT, fundraising, communication, human resources, and within our Enterprise unit, which negotiates collaborations between ICR scientists and industry.
The Enterprise Unit acts as the technology and knowledge transfer hub for The Institute of Cancer Research, providing the experience and expertise to put in place a wide range of agreements between our scientists and industry.
Although it is not our primary objective, the ICR has been extremely successful in getting a financial return from the commercial exploitation of its research. This income is largely ploughed back into scientific research at the ICR.
We currently have a number of partnering and licensing opportunities in therapeutics, targets, diagnostic biomarkers, devices, and platform or software applications."
- 4573 Biotechnology
- Company Number
- Private Limited by Guarantee/No Share Capital
- Company Age
- 64 years
- June 4, 1954
- Nature of Business
- 72190 - Other research and experimental development on natural sciences and engineering
- Year End
- July 31
- Accounts Due
- April 30, 2019
- Latest Accounts
- July 31, 2017
The Institute of Cancer Research, LondonSource:www.icr.ac.uk
The Institute of Cancer Research, London, is one of the world's most influential ... through the discovery of innovative new approaches to cancer treatment.
Institute of Cancer Research - Royal Marsden Hospital. Cancer ...Source:ecancer.org
Institute of Cancer Research - Royal Marsden Hospital. About. The ICR is a College of the University of London and, in association with the Royal Marsden NHS ...
The Royal Marsden NHS Foundation Trust - The Institute of Cancer ...Source:www.icr.ac.uk
The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The ...
The Institute of Cancer Research | LinkedInSource:www.linkedin.com
See who you know at The Institute of Cancer Research, leverage your ... year and together with our hospital partner, The Royal Marsden NHS Foundation Trust , ...
Institute of Cancer Research - WikipediaSource:en.wikipedia.org
The Institute of Cancer Research (the ICR) is a public research institute and a constituent college of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined .... A randomised placebo-controlled Phase III trial reported in October 2010 that ...
The Institute of Cancer Research, London | University of LondonSource:london.ac.uk
The Institute of Cancer Research, London, is one of the world's most influential ... basic research and translational studies, and with its partner The Royal Marsden ... form one of the world's top four centres for cancer research and treatment.
MARKET: M&A to ScaleUp
MARKET: Legaltech to the Crick
MARKET: Green power to Nanobots
COMPANIES: Ede & Ravenscroft to MRC
MARKET: Biotech Clusters to Ransomware
MARKET: Accelerators to Big Data
MARKET: Foodtech to Smart Cities
MARKET: Circular Economy to Industrial Internet
COMPANIES: Oxford Sciences Innovation to Wimbledon
UK business delegation to China
MARKET: Bad Advice to UK Disruptors
COMPANIES: Metrasens to Otaq
MARKET: Health Tech to Station F, Paris
MARKET: Drones to Deep Tech
MARKETPLACE: media stories 2015-18
MARKET: Gazelles to Industrial Internet
COMPANIES: Perkbox to Revolut
COMPANIES: Itsu to Cambridge Innovation Capital
MARKET: Bioelectronics to Chinese Investment
COMPANIES: Jellycat to Kymab
MARKET: Cash Burn to Workspace
New Year's resolution: visit Station F, Paris
MARKET: Spin-outs to Science Parks
MARKET: Startup Successes to Tech Nation
COMPANIES: Giraffe to Xupes
MARKET: Cyber Security to AI
Wendy Tan White to join BGF Ventures
Queen’s Awards for Enterprise winners 2016
COMPANIES: Alfa to Tokamak Energy
RT @ICR_CTSU: We are currently recruiting for a number of different statistical roles within ICR-CTSU - find out more and apply here: https…
#ICRjobs The ICR is seeking to appoint an exceptional Team Leader to join the @BreastCancerNow Toby Robins Research… https://t.co/BcE0xiVhYD
The ICR has issued a statement in response to the @US_FDA's approval of #talazoparib for women with BRCA-mutant adv… https://t.co/0jnnlmE101
#ICRprofile Dr Olivia Rossanese investigates new therapeutic targets for the treatment of cancer… https://t.co/8WP78PF20K
Read more about the work of Professor Ros Eeles' Oncogenetics Team: https://t.co/q2YELRN76y https://t.co/Lz6QmHHAbe
#ICRjobs Team Leader in Drug Discovery Biology for Paediatric Brain Tumours. This is a unique opportunity to establ… https://t.co/Yfo4qU5Kr5
@officepowerltd Good luck and thanks for supporting us!
Read the inspiring story of how Matt rode 250km across Norway and Sweden on a husky sled to live by his late grandf… https://t.co/xOCI0Or9kp
BLOG: Professor Chris Lord (@IcrLordLab), has given his inaugural lecture to mark his promotion to Professor after… https://t.co/TBJ1Fdrtc9